|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: ETFA |
Gene summary for ETFA |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | ETFA | Gene ID | 2108 |
| Gene name | electron transfer flavoprotein subunit alpha | |
| Gene Alias | EMA | |
| Cytomap | 15q24.2-q24.3 | |
| Gene Type | protein-coding | GO ID | GO:0006082 | UniProtAcc | A0A0S2Z3L0 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 2108 | ETFA | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.90e-12 | -3.98e-01 | 0.0155 |
| 2108 | ETFA | HTA11_347_2000001011 | Human | Colorectum | AD | 4.64e-05 | 4.38e-01 | -0.1954 |
| 2108 | ETFA | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.61e-06 | -4.09e-01 | 0.3859 |
| 2108 | ETFA | HTA11_99999974143_84620 | Human | Colorectum | MSS | 5.98e-04 | -3.38e-01 | 0.3005 |
| 2108 | ETFA | A001-C-207 | Human | Colorectum | FAP | 4.82e-04 | -2.20e-01 | 0.1278 |
| 2108 | ETFA | A015-C-203 | Human | Colorectum | FAP | 7.50e-29 | -4.42e-01 | -0.1294 |
| 2108 | ETFA | A015-C-204 | Human | Colorectum | FAP | 2.24e-10 | -4.76e-01 | -0.0228 |
| 2108 | ETFA | A014-C-040 | Human | Colorectum | FAP | 1.30e-05 | -4.48e-01 | -0.1184 |
| 2108 | ETFA | A002-C-201 | Human | Colorectum | FAP | 5.49e-16 | -4.50e-01 | 0.0324 |
| 2108 | ETFA | A002-C-203 | Human | Colorectum | FAP | 2.34e-05 | -2.10e-01 | 0.2786 |
| 2108 | ETFA | A001-C-119 | Human | Colorectum | FAP | 3.46e-14 | -5.82e-01 | -0.1557 |
| 2108 | ETFA | A001-C-108 | Human | Colorectum | FAP | 1.80e-17 | -4.27e-01 | -0.0272 |
| 2108 | ETFA | A002-C-205 | Human | Colorectum | FAP | 2.09e-22 | -4.83e-01 | -0.1236 |
| 2108 | ETFA | A001-C-104 | Human | Colorectum | FAP | 6.28e-09 | -2.94e-01 | 0.0184 |
| 2108 | ETFA | A015-C-005 | Human | Colorectum | FAP | 6.79e-05 | -3.34e-01 | -0.0336 |
| 2108 | ETFA | A015-C-006 | Human | Colorectum | FAP | 9.74e-18 | -5.84e-01 | -0.0994 |
| 2108 | ETFA | A015-C-106 | Human | Colorectum | FAP | 2.55e-15 | -4.16e-01 | -0.0511 |
| 2108 | ETFA | A002-C-114 | Human | Colorectum | FAP | 6.04e-21 | -5.70e-01 | -0.1561 |
| 2108 | ETFA | A015-C-104 | Human | Colorectum | FAP | 3.08e-32 | -5.13e-01 | -0.1899 |
| 2108 | ETFA | A001-C-014 | Human | Colorectum | FAP | 2.22e-17 | -4.33e-01 | 0.0135 |
| Page: 1 2 3 4 5 6 7 8 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0006091 | Colorectum | AD | generation of precursor metabolites and energy | 209/3918 | 490/18723 | 3.17e-28 | 6.61e-25 | 209 |
| GO:0022900 | Colorectum | AD | electron transport chain | 89/3918 | 175/18723 | 1.42e-18 | 8.91e-16 | 89 |
| GO:0044282 | Colorectum | AD | small molecule catabolic process | 118/3918 | 376/18723 | 1.05e-06 | 3.55e-05 | 118 |
| GO:0006635 | Colorectum | AD | fatty acid beta-oxidation | 33/3918 | 74/18723 | 3.98e-06 | 1.09e-04 | 33 |
| GO:0009062 | Colorectum | AD | fatty acid catabolic process | 41/3918 | 100/18723 | 4.02e-06 | 1.09e-04 | 41 |
| GO:0019395 | Colorectum | AD | fatty acid oxidation | 40/3918 | 103/18723 | 2.43e-05 | 4.69e-04 | 40 |
| GO:0016042 | Colorectum | AD | lipid catabolic process | 97/3918 | 320/18723 | 4.31e-05 | 7.56e-04 | 97 |
| GO:0006631 | Colorectum | AD | fatty acid metabolic process | 114/3918 | 390/18723 | 5.58e-05 | 9.44e-04 | 114 |
| GO:0072329 | Colorectum | AD | monocarboxylic acid catabolic process | 44/3918 | 122/18723 | 8.05e-05 | 1.28e-03 | 44 |
| GO:0034440 | Colorectum | AD | lipid oxidation | 40/3918 | 108/18723 | 8.52e-05 | 1.32e-03 | 40 |
| GO:0030258 | Colorectum | AD | lipid modification | 67/3918 | 212/18723 | 1.66e-04 | 2.27e-03 | 67 |
| GO:0016054 | Colorectum | AD | organic acid catabolic process | 73/3918 | 240/18723 | 3.20e-04 | 3.81e-03 | 73 |
| GO:0044242 | Colorectum | AD | cellular lipid catabolic process | 66/3918 | 214/18723 | 3.96e-04 | 4.50e-03 | 66 |
| GO:0046395 | Colorectum | AD | carboxylic acid catabolic process | 70/3918 | 236/18723 | 9.06e-04 | 8.71e-03 | 70 |
| GO:00060912 | Colorectum | MSS | generation of precursor metabolites and energy | 186/3467 | 490/18723 | 1.14e-24 | 2.15e-21 | 186 |
| GO:00229002 | Colorectum | MSS | electron transport chain | 83/3467 | 175/18723 | 2.06e-18 | 1.17e-15 | 83 |
| GO:00090622 | Colorectum | MSS | fatty acid catabolic process | 32/3467 | 100/18723 | 8.28e-04 | 8.67e-03 | 32 |
| GO:00442822 | Colorectum | MSS | small molecule catabolic process | 94/3467 | 376/18723 | 9.85e-04 | 9.86e-03 | 94 |
| GO:00302582 | Colorectum | MSS | lipid modification | 57/3467 | 212/18723 | 1.64e-03 | 1.49e-02 | 57 |
| GO:00066312 | Colorectum | MSS | fatty acid metabolic process | 95/3467 | 390/18723 | 2.20e-03 | 1.84e-02 | 95 |
| Page: 1 2 3 4 5 6 7 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| ETFA | SNV | Missense_Mutation | c.626G>A | p.Arg209Gln | p.R209Q | P13804 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
| ETFA | SNV | Missense_Mutation | c.196G>T | p.Asp66Tyr | p.D66Y | P13804 | protein_coding | deleterious(0.02) | possibly_damaging(0.641) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
| ETFA | SNV | Missense_Mutation | c.626N>A | p.Arg209Gln | p.R209Q | P13804 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AA-A02W-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
| ETFA | SNV | Missense_Mutation | c.280N>G | p.Pro94Ala | p.P94A | P13804 | protein_coding | tolerated(0.19) | benign(0.309) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
| ETFA | SNV | Missense_Mutation | novel | c.893N>T | p.Ala298Val | p.A298V | P13804 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
| ETFA | SNV | Missense_Mutation | c.196N>T | p.Asp66Tyr | p.D66Y | P13804 | protein_coding | deleterious(0.02) | possibly_damaging(0.641) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
| ETFA | SNV | Missense_Mutation | c.986T>C | p.Ile329Thr | p.I329T | P13804 | protein_coding | tolerated(0.45) | benign(0) | TCGA-A5-A0GP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
| ETFA | SNV | Missense_Mutation | novel | c.983A>C | p.Glu328Ala | p.E328A | P13804 | protein_coding | tolerated(0.24) | benign(0.001) | TCGA-A5-A1OH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | CR |
| ETFA | SNV | Missense_Mutation | novel | c.483G>T | p.Glu161Asp | p.E161D | P13804 | protein_coding | tolerated(1) | benign(0.007) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| ETFA | SNV | Missense_Mutation | rs865839624 | c.137G>A | p.Arg46His | p.R46H | P13804 | protein_coding | deleterious(0.05) | benign(0.001) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
| Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |